According to Novocure 's latest financial reports the company's total assets are $1.14 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $1.14 B | -3.82% |
2022-12-31 | $1.19 B | 4.58% |
2021-12-31 | $1.13 B | 8.32% |
2020-12-31 | $1.05 B | 119.42% |
2019-12-31 | $0.47 B | 41.1% |
2018-12-31 | $0.33 B | 28.08% |
2017-12-31 | $0.26 B | -5.95% |
2016-12-31 | $0.28 B | -8.22% |
2015-12-31 | $0.30 B | 160.73% |
2014-12-31 | $0.11 B | -37.6% |
2013-12-31 | $0.18 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $8.88 M | -99.23% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.20 B | -82.35% | ๐ฌ๐ง UK |
Novavax NVAX | $1.79 B | 56.83% | ๐บ๐ธ USA |
Novocure
NVCR | $1.14 B | 0.00% | Jersey |